Wound healing composition and method for use thereof

Abstract

A method for reducing or preventing the formation of scar tissue is disclosed. The method comprises applying a pharmacologically effective amount of a composition comprising about 5.0% by weight of ovalbumin, about 1.0% phenoxyethanol, about 0.5% carbomer, and about 0.3% triethanolamine. A method for stimulating fibroblast production is also disclosed. The method comprises applying a pharmacologically effective amount of a composition comprising about 5.0% by weight of ovalbumin, about 1.0% phenoxyethanol, about 0.5% carbomer, and about 0.3% triethanolamine.

I claim:  
     
         1 . A method for reducing or preventing the formation of scar tissue in a subject comprising: applying a pharmacologically effective amount of a composition to the subject, the composition comprising about 5.0% to 20% by weight crude ovalbumin containing a growth factor selected from the group consisting of epidermal growth factor, transforming growth factor alpha, fibroblast growth factor alpha, and fibroblast growth factor basic; about 1.0% by weight phenoxyethanol, about 0.5% by weight carbomer; and about 0.3% by weight triethanolamine; wherein the composition reduces or prevents the formation of scar tissue in the subject.  
     
     
         2 . The method of  claim 1 , wherein the growth factor is epidermal growth factor.  
     
     
         3 . The method of  claim 1 , wherein the growth factor is transforming growth factor.  
     
     
         4 . The method of  claim 1 , wherein the growth factor is fibroblast growth factor alpha.  
     
     
         5 . The method of  claim 1 , wherein the growth factor is fibroblast growth factor basic.  
     
     
         6 . The method of  claim 1 , wherein the composition is in the form of a topical composition.  
     
     
         7 . The method of  claim 1 , wherein the composition is in the form of a gel, cream, lotion, ointment or powder.  
     
     
         8 . A method for stimulating fibroblast production in a subject comprising: applying a pharmacologically effective amount of a composition to the subject, the composition comprising about 5.0% to 20% by weight crude ovalbumin containing a growth factor selected from the group consisting of epidermal growth factor, transforming growth factor alpha, fibroblast growth factor alpha, and fibroblast growth factor basic; about 1.0% by weight phenoxyethanol, about 0.5% by weight carbomer; and about 0.3% by weight triethanolamine; wherein the composition stimulates fibroblast production in the subject.  
     
     
         9 . The method of  claim 1 , wherein the growth factor is epidermal growth factor.  
     
     
         10 . The method of  claim 1 , wherein the growth factor is transforming growth factor.  
     
     
         11 . The method of claim I, wherein the growth factor is fibroblast growth factor alpha.  
     
     
         12 . The method of  claim 1 , wherein the growth factor is fibroblast growth factor basic.  
     
     
         13 . The method of  claim 1 , wherein the composition is in the form of a topical composition.  
     
     
         14 . The method of  claim 1 , wherein the composition is in the form of a gel, cream, lotion, ointment or powder.